Aditxt

+$0.0003 (+0.11%) As of 1:52 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aditxt and other ETFs, options, and stocks.

About ADTX

Aditxt, Inc. engages in the development of biotechnologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. It has a worldwide license for commercializing a nucleic acid-based technology, named Apoptotic DNA Immunotherapy (ADi), which utilizes a novel approach that mimics the way the body naturally induces tolerance to its own tissue.

CEO
Amro Albanna
Employees
58
Headquarters
Richmond, Virginia
Founded
2017

ADTX Key Statistics

Market cap
12.04M
Price-Earnings ratio
—
Dividend yield
—
Average volume
379.93K
High today
$0.27
Low today
$0.2651
Open price
$0.27
Volume
24.65K
52 Week high
$3.95
52 Week low
$0.2412

ADTX Earnings

-$0.97
-$0.65
-$0.32
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected May 31, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure